Royal Jordanian’s board’s meeting was held on June 21, 2016. RJ’s Board of Directors elected Said Darwazah Chairman of the Board of Directors.
Darwazah was appointed a representative of the Government Shareholdings’ Management Company in RJ’s Board of Directors as of June 19, 2016, replacing Suleiman Hafez, who chaired the RJ board of directors since November 2014.
RJ’s president/CEO Captain Suleiman Obeidat was appointed a representative of the Government Shareholdings’ Management Company in RJ’s Board of Directors occupying the vacant seat.
The Board of Directors is comprised of 9 members; five of them represent the Government Shareholdings’ Management Company that owns 60.2% of the RJ capital which amounts to 146.4 million dinars/shares.
Darwazah has a B.Sc. degree in industrial engineering from Purdue University in the USA and an MBA from INSEAD University, France.
Said Darwazah is currently the CEO and Chairman of Hikma Pharmaceuticals PLC. Between 2003 and 2006, he was the Minister of Health, Jordan.
He is also the Chairman of the Board of the Queen Rania Foundation, which focuses primarily on providing youth with learning opportunities and equipping them with the necessary tools for success such as ICT in education and online learning opportunities.
Darwazah occupies the chairmanship of the Board of Trustees of the Jordan University of Science and Technology (JUST), and is a board member of the Central Bank of Jordan.
He is a member of the Board of Trustees at Babson College in the USA, and the American University of Beirut (AUB), where he also co-founded the Samih Darwazah Center for Innovation Management and Entrepreneurship.
Darwazah also founded the Health Care Accreditation Council in Amman, a not-for-profit organization that accredits healthcare providers and works across the region to improve standards in healthcare.